Stux Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Stux Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$2.23M	Sell	18,100 -9,100	-33%	-$1.01M	0.29%	97
2014 Q1	$2.82M	Sell	27,200 -7,100	-21%	-$727K	0.35%	90
2013 Q4	$3.08M	Buy	34,300 +1,300	+4%	+$104K	0.37%	81
2013 Q3	$2.21M	Sell	33,000 -3,200	-9%	-$221K	0.29%	110
2013 Q2	$2.4M	Buy	+36,200	New	+$2.07M	0.3%	95

Other funds holding SLXP

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stux Capital Management's SLXP Position: Q2 2014 in Review

Stux Capital Management reduced its SALIX PHARMACEUTICALS LTD DEL (SLXP) stake by 33% in Q2 2014, selling an estimated $1.01M and leaving 18,100 shares worth $2.23M. The position accounts for 0.29% of the portfolio, ranked #97.

Stux Capital Management first reported a position in SLXP in Q2 2013 and has held it in 5 quarters since. The position peaked at $3.08M in Q4 2013. 308 funds tracked by Wall St. Rank hold SLXP as of Q2 2014.

Stux Capital Management held 18,100 shares of SALIX PHARMACEUTICALS LTD DEL worth $2.23M as of Q2 2014.
Stux Capital Management sold 9,100 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2014, an estimated $1.01M.
SALIX PHARMACEUTICALS LTD DEL made up 0.29% of Stux Capital Management's portfolio in Q2 2014, its #97 holding.
Stux Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and has held it in 5 quarters since.
Stux Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.08M in Q4 2013.
308 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2014.

Based on Stux Capital Management's 13F filing for Q2 2014, filed 14 Jul 2014.